A research team led by the University of Adelaide has helped develop a groundbreaking new device that significantly improves the efficiency of the only fertility treatment currently available for men with low sperm counts.
Created in partnership with medical tech company Fertilis, this first-of-its-kind device will enable more IVF (in vitro fertilisation) clinics to offer a treatment called Intracytoplasmic Sperm Injection (ICSI), a slow and difficult treatment that involves injecting a single sperm into an oocyte (egg) for fertilisation.